Φορτώνει......
The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells
Although ErbB receptors have been implicated in prostate cancer progression, ErbB-directed drugs have not proven effective for prostate cancer treatment. The ErbB3-binding protein EBP1 affects both ErbB2 and androgen receptor signaling, two components of the response to ErbB-targeted therapies. We t...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Cell Biochem |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449279/ https://ncbi.nlm.nih.gov/pubmed/25876877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11010-015-2409-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|